No idea. But having talked to surgeons, my understanding is that they are more likely to try drugs and devices adapted from established products for different uses, than that of a new product from a completely new technology.
They also have access to more information and can also ask colleagues about their experiences as well. This is different to when BTM was launched and no one knew what the heck NovoSorb was.
If they can access information knowing that NovoSorb has been well received by a range of patients, even if it was for a different surgery, the take up rate can be expected to be higher.
Yes, surgeons can specialiase in certain procedures but it's not like the guys doing hernia surgeries have their own clique that precludes them from talking to the docs doing other surgeries.
- Forums
- ASX - By Stock
- PNV
- PNV Media Thread
PNV Media Thread, page-390
-
- There are more pages in this discussion • 2,829 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.28 |
Change
-0.025(1.09%) |
Mkt cap ! $1.553B |
Open | High | Low | Value | Volume |
$2.33 | $2.34 | $2.24 | $1.863M | 818.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 9699 | $2.27 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.28 | 18261 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
29 | 10532 | 2.270 |
22 | 47091 | 2.260 |
12 | 30865 | 2.250 |
17 | 63186 | 2.240 |
14 | 133424 | 2.230 |
Price($) | Vol. | No. |
---|---|---|
2.280 | 18458 | 15 |
2.290 | 38913 | 15 |
2.300 | 58193 | 17 |
2.310 | 118572 | 9 |
2.320 | 19151 | 7 |
Last trade - 15.58pm 15/07/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online